State SC
Clinical Trials in South Carolina
Recruiting clinical trials with at least one study location in South Carolina. Data updated daily from ClinicalTrials.gov.
Top Conditions in South Carolina
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT05668741 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)
Condition
Cystic Fibrosis
Enrollment
39 pts
Location
United States, Australia, Belgium
Sponsor
Vertex Pharmaceuticals Incorpo
NCT07179822 N/A
Recruiting
Motoneuron Recruitment and Motor Evoked Potential Up-Conditioning (MEP) in Spina...
Condition
Spinal Cord Injuries and Disorders (SCI/D)
Enrollment
15 pts
Location
United States
Sponsor
Medical University of South Ca
NCT06321302 Phase 2
Recruiting
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diab...
Condition
Diabetic Retinopathy
Enrollment
178 pts
Location
United States, Germany, Hungary
Sponsor
Boehringer Ingelheim
NCT07018700 Phase 3
Recruiting
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preve...
Condition
Episodic Migraine
Enrollment
990 pts
Location
United States, Austria, Czechia
Sponsor
Merz Therapeutics GmbH
NCT03948893 N/A
Recruiting
Smoking Cessation Behavioral Treatment Study
Condition
Tobacco Use Disorder
Enrollment
200 pts
Location
United States
Sponsor
University of Missouri-Columbi
NCT05642572 Phase 2
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
66 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT04042844 Phase 2
Recruiting
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
Condition
Lumbar Disc Disease
Enrollment
99 pts
Location
United States
Sponsor
BioRestorative Therapies
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06052072 N/A
Recruiting
Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation Syste...
Condition
Group 2 Pulmonary Hypertension
Enrollment
50 pts
Location
United States
Sponsor
Gradient Denervation Technolog
NCT06486428 N/A
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In
NCT07144436 N/A
Recruiting
Post-stroke Pain tAN-fMRI
Condition
Post Stroke Pain
Enrollment
24 pts
Location
United States
Sponsor
Medical University of South Ca
NCT07176234 N/A
Recruiting
The LEADS Trial (Linking Exericise for Advancing Daily Stress Management)
Condition
Obesity, Childhood
Enrollment
330 pts
Location
United States
Sponsor
University of South Carolina
NCT07207811 Phase 3
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine...
Condition
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Enrollment
1,280 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04429542 Phase 1
Recruiting
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therap...
Condition
Head and Neck Squamous Cell Carcinoma
Enrollment
292 pts
Location
United States, Australia, Canada
Sponsor
Bicara Therapeutics
NCT04752722 Phase 1, Phase 2
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incom...
Condition
Superficial Bladder Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
enGene, Inc.
NCT05862272 Phase 3
Recruiting
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugoli...
Condition
Uterine Fibroids
Enrollment
1,000 pts
Location
United States
Sponsor
Sumitomo Pharma Switzerland Gm
NCT04712877 N/A
Recruiting
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patien...
Condition
NSCLC
Enrollment
1,000 pts
Location
United States
Sponsor
Lung Cancer Mutation Consortiu
NCT06506942 N/A
Recruiting
The TRICURE EFS Study
Condition
Tricuspid Valve Regurgitation
Enrollment
15 pts
Location
United States
Sponsor
TRiCares
NCT07040566 Phase 2
Recruiting
A Trial of Varenicline for E-cigarette Cessation
Condition
E-cigarette Use
Enrollment
326 pts
Location
United States
Sponsor
Yale University
NCT06784466 N/A
Recruiting
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patie...
Condition
Atrial Fibrillation (AF)
Enrollment
360 pts
Location
United States, Belgium, Croatia
Sponsor
Arga Medtech SA
NCT05975983 Phase 2
Recruiting
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulm...
Condition
Idiopathic Pulmonary Fibrosis (IPF)
Enrollment
40 pts
Location
United States
Sponsor
InSilico Medicine Hong Kong Li
NCT05650541 N/A
Recruiting
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in...
Condition
Heart Failure
Enrollment
1,200 pts
Location
United States
Sponsor
Analog Device, Inc.
NCT06651177 Phase 2
Recruiting
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Op...
Condition
Opioid Use Disorder
Enrollment
310 pts
Location
United States
Sponsor
T. John Winhusen, PhD